NLRP3-inflammasome inhibition by MCC950 attenuates cardiac and pulmonary artery remodelling in heart failure with preserved ejection fraction

Xiaocheng Cheng(The Affiliated Yongchuan Hospital of Chongqing Medical University), Dongying Zhang(Huaian First People’s Hospital), Shuliang Guo(Apple (Israel)), Xuesong Wen(The Affiliated Yongchuan Hospital of Chongqing Medical University), Guoxing Li(Wenzhou Medical University), Hanru Zhao(Chongqing Medical University)
Life Sciences
October 17, 2023
Cited by 33


Related Papers